Romel Rosales

MedicineComputer ScienceImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A”.

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

Science(2021)10.1126/science.abf4058

N/A

9.0DataRank · unranked

365 citations

Romel Rosales, Soner Yildiz, Thomas Kehrer, Lisa Miorin, Elena Moreno +21 more

Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.24.427991

N/A

2.4DataRank · unranked

42 citations

Lucy G. Thorne, Lorena Zuliani‐Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Joseph Hiatt +18 more

SARS-CoV-2 variants evolve convergent strategies to remodel the host response

Cell(2023)10.1016/j.cell.2023.08.026

N/A

2.1DataRank · unranked

113 citations

Ann-Kathrin Reuschl, Benjamin J. Polacco, Lucy G. Thorne, Manisha R. Ummadi, Chengjin Ye +88 more

Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

Life Science Alliance(2022)10.26508/lsa.202101200

N/A

1.2DataRank · unranked

52 citations

Pedro Landete, José A. López-Martín, Vicente Estrada, Roger Paredes, Pablo Guisado‐Vasco +46 more

Evolution of enhanced innate immune evasion by SARS-CoV-2

Nature(2021)10.1038/s41586-021-04352-y

N/A

0.900DataRank · unranked

402 citations

Mehdi Bouhaddou, Ann-Kathrin Reuschl, Lorena Zuliani-Alvarez, Benjamin J. Polacco, Adrian Pelin +41 more

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Nature Communications(2021)10.1038/s41467-021-26239-2

N/A

0.855DataRank · unranked

297 citations

Rhys Jones, Brandon J. Anson, Dan Arenson, Lisa Aschenbrenner, Malina A. Bakowski +47 more

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Science(2021)10.1126/science.abi4708

N/A

0.812DataRank · unranked

224 citations

Veronica V. Rezelj, Benoit Fischer, Audrey Fischer, Matthew J. O’Meara, Blandine Monel +24 more

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

Cell Reports(2021)10.1016/j.celrep.2021.109133

N/A

0.657DataRank · unranked

79 citations

Kris M. White, Balasubramanian Harish, Romel Rosales, Theresa A. Ramelot, Thomas Acton +8 more

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19

Scientific Reports(2021)10.1038/s41598-021-91625-1

N/A

0.601DataRank · unranked

54 citations

Gaia Andreoletti, Tomiko Oskotsky, Albert Vallejo-Gracia, Romel Rosales, Katharine Yu +10 more

Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection

Nature Genetics(2023)10.1038/s41588-023-01307-z

N/A

0.571DataRank · unranked

44 citations

Ajinkya Patil, Clayton K. Collings, Mia Madel Alfajaro, Yu Liang, Wesley L. Cai +23 more

Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.19.512927

N/A

0.524DataRank · unranked

14 citations

Ann‐Kathrin Reuschl, Benjamin J. Polacco, Lucy G. Thorne, Manisha R. Ummadi, Chengjin Ye +72 more

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.23.352666

N/A

0.426DataRank · unranked

7 citations

Gaia Andreoletti, Tomiko Oskotsky, Albert Vallejo-Gracia, Romel Rosales, Katharine Yu +10 more

The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infection

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease(2024)10.1016/j.bbadis.2024.167193

N/A

0.385DataRank · unranked

12 citations

Arturo Marín, Romel Rosales, Rebekah Penrice-Randal, Petra Mlčochová, Yolanda Álvarez +26 more

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19

Research Square(2021)10.21203/rs.3.rs-333578/v1

N/A

0.241DataRank · unranked

4 citations

Gaia Andreoletti, Tomiko Oskotsky, Albert Vallejo-Gracia, Romel Rosales, Katharine Yu +10 more

Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity

ACS Infectious Diseases(2022)10.1021/acsinfecdis.2c00008

N/A

0DataRank · unranked

24 citations

Laura Martin‐Sancho, Ranjala Ratnayake, Kris M. White, Laura Riva, Qi-Yin Chen +20 more

Bat pluripotent stem cells reveal unusual entanglement between host and viruses

Cell(2023)10.1016/j.cell.2023.01.011

N/A

0DataRank · unranked

60 citations

Arturo Marín, Graham M. Hughes, Ariadna E. Morales, Carlos Godoy-Parejo, Jonathan L. Gray +20 more